Home › Funds › EMERALD ADVISERS, LLC › AGYS
EMERALD ADVISERS, LLC position in AGYS
AGILYSYS INC · Technology
EMERALD ADVISERS, LLC reported holding 431,438 shares of AGYS (AGILYSYS INC) in its Q3 2026 13F filing — a position valued at US$41.9M, representing 1.15% of its reported portfolio and ranking #26 among its reported holdings. EMERALD ADVISERS, LLC has disclosed AGYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How EMERALD ADVISERS, LLC's AGYS position evolved
EMERALD ADVISERS, LLC first disclosed a stake in AGYS in Q3 2023 at 208,388 shares (US$13.8M). The position peaked in Q2 2026 at 427,845 shares, worth US$44.7M. Across 13 filings, EMERALD ADVISERS, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 431,438 shares valued at US$41.9M — an increase of 3,593 shares quarter over quarter.. Notable position changes include a 44% increase in Q2 2025 (shares fell 8% over the following quarter), a 32% increase in Q2 2026 (shares fell 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 208.39K | $13.79M | New |
| Q4 2023 | 203.75K | $17.28M | Reduce |
| Q1 2024 | 247.87K | $20.89M | Add |
| Q2 2024 | 240.34K | $25.03M | Reduce |
| Q3 2024 | 239.46K | $26.09M | Hold |
| Q4 2024 | 234.01K | $30.82M | Reduce |
| Q1 2025 | 233.49K | $16.94M | Hold |
| Q2 2025 | 337.10K | $38.65M | Add |
| Q3 2025 | 329.98K | $34.73M | Reduce |
| Q4 2025 | 328.43K | $39.03M | Hold |
| Q1 2026 | 323.51K | $23.01M | Reduce |
| Q2 2026 | 427.85K | $44.71M | Add |
| Q3 2026 | 431.44K | $41.88M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AGYS and 13F data
AGYS (AGILYSYS INC) is a Technology company. 34 other funds we track also report a position in AGYS — the largest reported positions include MAK CAPITAL ONE LLC (US$124.6M), AltraVue Capital, LLC (US$53.5M), GENEVA CAPITAL MANAGEMENT LLC (US$45.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AGYS
- MAK CAPITAL ONE LLC 1.19M sh · $124.64M · Q2 2026
- AltraVue Capital, LLC 550.77K sh · $53.47M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 465.18K sh · $45.16M · Q3 2026
- Conestoga Capital Advisors, LLC 385.29K sh · $37.40M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 354.80K sh · $34.44M · Q3 2026
More on EMERALD ADVISERS, LLC
FAQ
How long has EMERALD ADVISERS, LLC held AGYS?
EMERALD ADVISERS, LLC has disclosed AGYS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EMERALD ADVISERS, LLC's current position in AGYS?
As of Q3 2026, EMERALD ADVISERS, LLC holds 431.44K shares of AGYS (AGILYSYS INC), valued at $41.88M, representing 1.15% of its reported portfolio and ranking #26.
Has EMERALD ADVISERS, LLC been buying or selling AGYS?
In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in AGYS. The position peaked in Q2 2026 at 427.85K shares.
Which other funds hold AGYS?
Other major institutional holders of AGYS include MAK CAPITAL ONE LLC, AltraVue Capital, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.